Patrik Brundin (Former)
111 – 120 of 248
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain.
(
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
(
- Contribution to journal › Letter
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
(
- Contribution to journal › Article
-
Mark
High-fat diet impairs hippocampal neurogenesis in male rats.
(
- Contribution to journal › Article
-
Mark
Enriched Environment Attenuates Cell Genesis in Subventricular Zone After Focal Ischemia in Mice and Decreases Migration of Newborn Cells to the Striatum.
(
- Contribution to journal › Article
-
Mark
Transplantation in Parkinson's disease: The future looks bright.
(
- Contribution to journal › Article